InvestorsHub Logo
Followers 91
Posts 3296
Boards Moderated 0
Alias Born 10/18/2010

Re: Tha Part Time Er post# 4405

Monday, 07/27/2020 9:06:21 AM

Monday, July 27, 2020 9:06:21 AM

Post# of 13472
July 27 (Reuters) - Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial evaluating its COVID-19 vaccine candidate, mRNA-1273, in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.

The main goal of the study will be prevention of the symptomatic COVID-19 disease, the company said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News